Protein Degradation & Targeting Undruggables European Congress
11
Oct
-
12
Oct
2022
When
Basel
Switzerland
Where

The field of protein degradation has accelerated, and substantial interest is owed to its promise to therapeutically degrade proteins proving intractable to classical small molecule inhibition. As the field patiently waits for clinical trial readouts, some say we are entering the next era, beyond current targets and disease indications.

Similar Events

You May Like

Event

Hanson Wade

0/5
(0)

Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.

11 - 12 Oct 2022
In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

Executive Director
Director of Oncology Drug Discovery
Vice President, Protein Degradation Platform
Director, New Modalities & TPD global initiative co-lead
Director
Senior Scientist
Director
Co-Founder and Head of Degrader Biochemistry
EVP, Head of Drug Discovery
Co-Founder, Chief Executive Officer
PhD candidate
Founder & Chief Executive Officer

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Nanome

Nanome is a software company that is changing the way humanity understands and interacts with science. Using Virtual Reality our technology accelerates innovation and understanding in an intuitive manner.

Refeyn

Refeyn, the pioneer of mass photometry, is delivering a disruptive new generation of analytical instruments that let you weigh individual molecules with light.

Proteome Sciences plc

Proteome Sciences plc is a specialist provider of contract proteomics services to enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids.

Promega Corporation

At Promega Corporation, creativity and connection drive discovery and innovation. We celebrate scientific discovery and the creative application of science to solve problems.

Ainnocence

Ainnocence [aɪnəsens] is a next-generation biotech aiming to create a self-evolving modularized intelligent platform that integrates various advanced computational and wet lab technologies to revolutionize the drug discovery and development process.

NanoTemper Technologies

NanoTemper Technologies is deeply committed to the best customer experience. Central to this is a strong focus on high quality products made in Germany that enable researchers to easily, efficiently, and accurately perform protein characterization.

NEOsphere Biotechnologies GmbH

NEOsphere Biotechnologies is a pioneering proteomics company that creates value in strategic partnerships developing small molecule degraders as therapeutic agents against disease targets not yet exploited.

Organizer

Get emails from us

Thank you
Oops! Something went wrong